Classical Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Classical Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial results of NUC-3373 in combination with other agents in patients with advanced solid tumors; study status terminated with re…
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating magrolimab plus pembrolizumab in relapsed or refractory classic Hodgkin lymphoma has been terminated with results p…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents [Phase 3]
This clinical trial update reports the completion of a Phase 3 international inter-group study evaluating treatment for Classical Hodgkin Ly…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating Brentuximab Vedotin as consolidation therapy after allogeneic stem cell transplantation in relapsed or refractory c…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Study of Bendamustine, Gemcitabine and Vinorelbine Regimen in Relapsed/Refractory Classical Hodgkin Lymphoma [Phase 3]
Completed Phase 3 clinical trial evaluating a bendamustine/gemcitabine/vinorelbine regimen in relapsed/refractory classical Hodgkin lymphoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma [Phase 3]
Phase 3 trial comparing tislelizumab monotherapy to salvage chemotherapy in relapsed/refractory Classical Hodgkin lymphoma; the study has be…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204) [Phase 3]
This update reports the completion of a Phase 3 trial (MK-3475-204/KEYNOTE-204) comparing pembrolizumab to brentuximab vedotin in relapsed o…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65) [Phase 2]
Phase 2 study evaluating pembrolizumab coformulated with berahyaluronidase alfa (MK-3475A) in relapsed or refractory classical Hodgkin lymph…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma [Phase 2]
This entry describes a Phase 2 clinical trial evaluating camrelizumab in combination with AVD as first-line therapy for patients with advanc…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma [NA]
This completed clinical trial examines recurrent XPO1 mutations and their prognostic value in patients with Classical Hodgkin Lymphoma.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluating tislelizumab in relapsed or refractory classical Hodgkin lymphoma has completed, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of nivolumab and ipilimumab in adults with HIV-associated relapsed or refractory classical Hodgkin …
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A first-in-human phase 1/2 trial of GEN3017 in classical Hodgkin lymphoma and non-Hodgkin lymphoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma [NA]
ClinicalTrials.gov reports a completed frontline trial comparing Brentuximab Vedotin with AVD versus ABVD chemotherapy in patients with adva…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of gemcitabine, bendamustine, and nivolumab in relapsed or refractory classical Hodgkin lymphoma …
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed [Phase 1]
Phase 1 trial evaluating CC-486 (oral azacitidine) in combination with nivolumab for patients with recurrent or refractory classical Hodgkin…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma [Phase 3]
This Phase 3 trial investigates nivolumab or brentuximab vedotin in combination with chemotherapy for newly diagnosed stage III-IV classical…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Itacitinib + Everolimus in Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial updating the combination of Itacitinib and Everolimus for Classical Hodgkin lymphoma with results posted in 2025.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 1]
Phase 1 trial update reports safety and preliminary efficacy of AZD7789 in patients with relapsed or refractory classical Hodgkin lymphoma. …
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma [Phase 2]
This document reports completion of a Phase 2 trial evaluating nivolumab plus the AVD chemotherapy regimen in patients with early-stage unfa…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy [Phase 2]
A Phase 2 trial evaluates whether adding radiotherapy to nivolumab can produce abscopal anti-tumor effects in relapsed classical Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab
The update examines safety of allogeneic hematopoietic cell transplantation in patients with classical Hodgkin lymphoma who were treated wit…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
Results from a Phase 2 trial evaluating ibrutinib in relapsed or refractory classical Hodgkin lymphoma have been completed and posted.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer [Phase 1]
Seagen's SEA-TGT (SGN-TGT) Phase 1 safety study in advanced cancers has been terminated. The study enrolled patients across multiple cancer …
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Microenvironmental Trial of Classical Hodgkin Lymphoma in Adolescents
A clinical trial titled 'Microenvironmental Trial of Classical Hodgkin Lymphoma in Adolescents' (NCT06814860) sponsored by IRCCS Azienda Osp…